Greg Koblentz, member of the Center’s Scientists Working Group on Biological and Chemical Security, co-authored an article in Think Global Health on using “minilateral” strategies for strengthening global biorisk management.
Opened for signature in 1972, the Biological and Toxin Weapons Convention (BWC) has proven to be remarkably durable. With its deliberately broad scope, the BWC continues to cover cutting-edge developments in genome editing and next-generation biotechnology that were far beyond the imagination of the diplomats who crafted the treaty. However, the mechanisms established to update the BWC are no longer fit for purpose. Countries committed to reducing the risks posed by the misuse of biology should explore alternative “minilateral” strategies for strengthening global biorisk management. Read more
